TPE in Septic Patients and Influence on Organ Failure
- Conditions
- Multiple Organ Failure
- Interventions
- Device: Therapeutic Plasma Exchange (TPE)
- Registration Number
- NCT02906345
- Lead Sponsor
- University of Rostock
- Brief Summary
Therapeutic plasma exchange (TPE) should used for patients with septic shock in a controlled, prospective study focusing on the organ functions of the patients.
- Detailed Description
Therapeutic plasma exchange (TPE) should used for patients with septic shock in a controlled, prospective study.
Investigators will study three groups:
1. untreated control group;
2. TPE group, plasma separation carried out by filtration;
3. TPE group, plasma separation carried out by centrifugation.
All treated patients should treated two (minimal) to five times by TPE, depending on the need of norephinephrine for the therapy. For each session 40 ml/kg body weight plasma should be exchange. Fluid resuscitation will be done with fresh frozen plasma. The study will focusing on the organ functions of the patients, especially liver-, kidney- and nervous function and also displayed in the SOFA score on study days 3 and 7.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Septic shock, beginning of shock < 24 hours
- Participation in an another clinical trial within the last 30 days
- Participation in this study at an earlier date
- Simultaneous participation in another clinical trial
- Pregnancy
- Unpredictable Bleeding (over 2 erythrocyte concentrates daily)
- Polyneuropathy (known before the beginning of sepsis)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description TPE-Centrifugation Therapeutic Plasma Exchange (TPE) Patients with septic shock, therapeutic plasma exchange, plasma separation using a centrifuge (Fresenius COM-TEC, PL1 Erythrozytapherese/Plasmabeutel Set) BMC standard treatment TPE-Filtration Group Therapeutic Plasma Exchange (TPE) Patients with septic shock, therapeutic plasma exchange, plasma separation using a filter (Fresenius MultiFiltrate, Kit 16 MPS P2 dry), BMC standard treatment
- Primary Outcome Measures
Name Time Method SOFA score ≥ 2 Punkte day 7 SOFA: Sepsis-related Organ Failure Assessment score
- Secondary Outcome Measures
Name Time Method 28-day survival day 28 Observation time 28 days
Hospital survival 1 year Leave the patients the hospital?
Trial Locations
- Locations (1)
Intensive Care Units PIT 1+2, University Hospital Rostock
🇩🇪Rostock, Germany